Screening for Cannabis and Alcohol Impairment
Our first-to-market AI product screens for cannabis impairment is being expanded to include screening for alcohol and opioids.
Quick, non-invasive, contactless screening
Fully automated without the need for personnel to operate
Indicates positive or negative result so safety protocols can be initiated
Employers, as well as law enforcement, test people for traces of cannabis, alcohol and opioids. However, they cannot determine if individuals are actually impaired.
Without the ability to determine impairment, it is not possible to accurately predict safety risk, particularly for cannabis which is now medically prescribed.
Rather than test for traces of substances, we use multispectral recognition technologies to capture data used by our AI models to screen for impairment.
Interested in becoming a Pilot Partner for our Impairment Screening Solutions?
Simply fill out the form below and we’ll be in touch.
In the News
TORONTO, ON / ACCESSWIRE / October 27, 2020 / PredictMedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to provide a corporate update on its recent activities in relation to its infectious disease screening technology and its remote...
Bets on a better future A select group of health systems and hospitals are differentiating themselves from their peers, investing in the innovations they need to navigate the long-term uncertainties imposed by COVID-19. These organizations have pinpointed innovation...
PredictMedix (CSE: PMED-OTCQB: PMEDF) CEO Dr Rahul Kushwah joined Steve Darling from Proactive to share details the company has partnered up with Versus Systems to integrate Versus' proprietary rewards platform with its proprietary remote patient monitoring platform...